Kristina W W Thiel

9PUBLICATIONS
15CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied geophysicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 05, 2025
ASSET: A Framework for Decoding Aptamer Specificity of an Enriched Library by Next-Generation Sequencing of Experimental Samples.

Maya Barros, Gayathri Kasirajan, Amara Jones

|Feb 26, 2025
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.

Andrea R Hagemann, Ian S Hagemann, David G Mutch

|Nov 28, 2023
Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer.

Kaitriana E Colling, Emily L Symons, Lorenzo Buroni

|Sep 16, 2022
Reply to E. Guerra et al.

Kimberly Kay Leslie, Kristina Thiel

|Jun 06, 2022
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

Kristina W Thiel, Eric J Devor, Virginia L Filiaci

|Aug 06, 2021
Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy.

Jianling Bi, Garima Dixit, Yuping Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Eric J Devor

3 joint publications

Kimberly Kay Leslie

2 joint publications

Andreea M Newtson

2 joint publications

David Mutch